I am a breastfeeding mother and i want to know if it is safe to use 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone? Is 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone safe for nursing mother and child? Does 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone extracts into breast milk? Does 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone has any long term or short term side effects on infants? Can 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone influence milk supply or can 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone decrease milk supply in lactating mothers?
- DrLact safety Score for 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
It is used topically to depict local lesion in the eye. Also used intravenously as a dye for angiographic test procedures. It is a photo-sensitizing drug: avoid using it in mothers whose infants are on phototherapy. American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding.
After intravenous use in a nursing mother, milk levels and the dose received by the infant are much higher. It is unlikely that these higher levels are problematic for most infants, but exposure to intense light, such as phototherapy, should probably be avoided for a few days after the maternal dose. Because absorption from the eye is limited, 9-(o-Carboxyphenyl)-6-hydroxy-3-isoxanthenone would not be expected to cause any adverse effects in breastfed infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.